ICAM1 and systemic inflammatory response syndrome: For example, increases in soluble Icam1 were associated with inflammatory responses, and some clinical studies used soluble Icam1 as a biomarker to classify patients with inflammatory diseases, as well as non-infectious systemic inflammatory responses syndrome (de Pablo et al., 2013).